Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.01)
# 2,838
Out of 4,842 analysts
209
Total ratings
23.58%
Success rate
-0.8%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.25 | +620.00% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $1.07 | +647.66% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.85 | +224.79% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.04 | +96.08% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.04 | -1.96% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.91 | +781.25% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.69 | +606.32% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.00 | +950.00% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $2.77 | +441.52% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $7 | $0.37 | +1,771.66% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.21 | +726.45% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.53 | +274.60% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.02 | +392.61% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.19 | +164.26% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.79 | +44,203.80% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.10 | +416.13% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.04 | +476.92% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.71 | +14,056.29% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.08 | +1,566.67% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.83 | +992.90% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.23 | +487,516.10% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $7.09 | +6,952.19% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $16.36 | +1,366.99% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.92 | +8,595.65% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.91 | +10,889.01% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.15 | +129,981.30% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.48 | +372.97% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.56 | +1,071.88% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.34 | +1,097.60% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $2.36 | +662.71% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.24 | +303.23% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $3.61 | +39,770.42% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $31.31 | -23.35% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.43 | +239,060.84% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.76 | +1,079,445.45% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.25
Upside: +620.00%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $1.07
Upside: +647.66%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.85
Upside: +224.79%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.04
Upside: +96.08%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.04
Upside: -1.96%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.91
Upside: +781.25%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.69
Upside: +606.32%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.00
Upside: +950.00%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $2.77
Upside: +441.52%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $7
Current: $0.37
Upside: +1,771.66%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.21
Upside: +726.45%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.53
Upside: +274.60%
Mar 4, 2025
Reiterates: Buy
Price Target: $5
Current: $1.02
Upside: +392.61%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.19
Upside: +164.26%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.79
Upside: +44,203.80%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.10
Upside: +416.13%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.04
Upside: +476.92%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.71
Upside: +14,056.29%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.08
Upside: +1,566.67%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.83
Upside: +992.90%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.23
Upside: +487,516.10%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $7.09
Upside: +6,952.19%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $16.36
Upside: +1,366.99%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.92
Upside: +8,595.65%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.91
Upside: +10,889.01%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.15
Upside: +129,981.30%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.48
Upside: +372.97%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.56
Upside: +1,071.88%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.34
Upside: +1,097.60%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $2.36
Upside: +662.71%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.24
Upside: +303.23%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $3.61
Upside: +39,770.42%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $31.31
Upside: -23.35%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.43
Upside: +239,060.84%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.76
Upside: +1,079,445.45%